Olivia Sgarbura(@oliviawriting) 's Twitter Profileg
Olivia Sgarbura

@oliviawriting

Surgical oncologist, art lover, curious researcher, world traveler, idealistic mother and woman

ID:594483683

calendar_today30-05-2012 10:18:37

2,6K Tweets

2,6K Followers

1,5K Following

Follow People
SFCO(@SFCOnco) 's Twitter Profile Photo

📣 Retour sur l'allocution de Jean-Marc Classe passant le relais de la présidence de la Société Francophone de Chirurgie Oncologique à Gwenael Ferron, et à Olivia Sgarbura, Vice-Présidente, à l'occasion de la 15ème édition du congrès !

📣 Retour sur l'allocution de Jean-Marc Classe passant le relais de la présidence de la Société Francophone de Chirurgie Oncologique à Gwenael Ferron, et à Olivia Sgarbura, Vice-Présidente, à l'occasion de la 15ème édition du congrès ! #oncologie #cancerologie
account_circle
Julie Hallet(@HalletJulie) 's Twitter Profile Photo

I'll be joining European Society of Surgical Oncology (ESSO) to talk small bowel NETs on June 12th

Reviewing pre-op assessment for SB NETs - what are your burning questions? what do you want to hear about? SoMe4Surgery SoMe4HPB NANETS

I'll be joining @ESSOnews to talk small bowel NETs on June 12th Reviewing pre-op assessment for SB NETs - what are your burning questions? what do you want to hear about? @me4_so @hpb_so @NANETS1
account_circle
SFCO(@SFCOnco) 's Twitter Profile Photo

📣 J-1 : nous sommes prêts à vous accueillir à la !
📍Rendez-vous des demain à la Cité des Congrès de Nantes pour deux journées passionnantes sur la thématique « Art et essais en en chirurgie oncologique ».

📣 J-1 : nous sommes prêts à vous accueillir à la #SFCO2024 ! 📍Rendez-vous des demain à la Cité des Congrès de Nantes pour deux journées passionnantes sur la thématique « Art et essais en en chirurgie oncologique ». #oncologie #oncologie
account_circle
Julie Hallet(@HalletJulie) 's Twitter Profile Photo

Metastatic NETs - for medical therapy?🦓

Though side to debate 😱🥊

Many benefits to surgery🔪in selected patients👉🏻QOL, symptom, therapy sparing

WHEN to chose medical therapy💊👉🏻when surgery can harm (primum non nocere), in aggressive NENs

Metastatic NETs - for medical therapy?🦓 Though side to debate #IHPBA24😱🥊 Many benefits to surgery🔪in selected patients👉🏻QOL, symptom, therapy sparing WHEN to chose medical therapy💊👉🏻when surgery can harm (primum non nocere), in aggressive NENs
account_circle
Marc Besselink(@MarcBesselink) 's Twitter Profile Photo

Very proud to present the new of the E-AHPBA in my presidential address at the world meeting in

1.EAHPBA Early Career Group: Alberto Balduzzi 🇮🇹 Aiste Gulla 🇱🇹 Olivia Sgarbura 🇫🇷
2.EAHPBA Online Academy: FrederikBerrevoet 🇧🇪 Somaiah Aroori 🇬🇧
3.EAHPBA

Very proud to present the new #Career #Pathway of the @EAHPBA in my presidential address at the #IHPBA24 world meeting in #CapeTown 1.EAHPBA Early Career Group: @albe_balduzzi 🇮🇹 Aiste Gulla 🇱🇹 @oliviawriting 🇫🇷 2.EAHPBA Online Academy: @berrevoet 🇧🇪 @somaiaharoori 🇬🇧 3.EAHPBA
account_circle
Kjetil Søreide(@ksoreide) 's Twitter Profile Photo

Thanks for your leadership Marc Besselink Great things ahead and a fantastic team to be part of! 🙌🏻👍🏻🤩🎓 very proud of the entire education committee team E-AHPBA too 🙌🏻🤩👍🏻 SoMe4HPB

account_circle
Patrick Starlinger_TELL International(@TELL_Starlinger) 's Twitter Profile Photo

Great presentation of our data on metabolic profiles in liver failure and it’s association with GLP-1 and 2 by Dr. Ammann IHPBA 2024 in the best of the best oral presentation session. Congrats Markus on this great achievement! Proud of you!

Great presentation of our data on metabolic profiles in liver failure and it’s association with GLP-1 and 2 by Dr. Ammann @IHPBA 2024 in the best of the best oral presentation session. Congrats Markus on this great achievement! Proud of you!
account_circle
Olivia Sgarbura(@oliviawriting) 's Twitter Profile Photo

Thank you Mohamed Abu Hilal for the invitation to be part of the consensus. Very intensive days with every minute well spent followed by occasions to get to know each other in Italian style. Big applause 👏🏼 E-AHPBA ILLS Robert Sutcliffe santi lopez ben Niki Rashidian

Thank you @Abuhilal9Abu for the invitation to be part of the #IEGUMILS consensus. Very intensive days with every minute well spent followed by occasions to get to know each other in Italian style. Big applause 👏🏼 @EAHPBA @ILLS_LAPLIVER @liveRPancSurg @LopezBenS @Niki_Rashidian
account_circle
Julie Hallet(@HalletJulie) 's Twitter Profile Photo

📢Cytoreduction for liver & peritoneal SB-NETs mets is worth it✨

👥 261 pts ➡️50 liver + peritoneal mets Mayo Clinic

OS, PFS and symptom-free survival↔️liver only cytoreduction
⤴️outcomes with ⤴️% cytoreduction

✅Consider surgery for peritoneal mets👉🏻refer to NET surgeons

📢Cytoreduction for liver & peritoneal SB-NETs mets is worth it✨ 👥 261 pts ➡️50 liver + peritoneal mets @MayoClinic OS, PFS and symptom-free survival↔️liver only cytoreduction ⤴️outcomes with ⤴️% cytoreduction ✅Consider surgery for peritoneal mets👉🏻refer to NET surgeons
account_circle
Kostas Votanopoulos(@KVotanopoulos) 's Twitter Profile Photo

Can we boost effectiveness with Bromelain?
Exciting new research from group, reveals its dual action as a mucolytic and cytotoxic agent, against appendiceal cancer organoids.
Dive in the study here: rdcu.be/dGZE2

account_circle
Olivia Sgarbura(@oliviawriting) 's Twitter Profile Photo

The consensus conference is starting. Happy to be in Brescia with such an impressive lineup of speakers. Great organisation already by Mohamed Abu Hilal with participation of E-AHPBA IHPBA ILLS

The #IEGUMILS consensus conference is starting. Happy to be in Brescia with such an impressive lineup of speakers. Great organisation already by @Abuhilal9Abu with participation of @EAHPBA @IHPBA @ILLS_LAPLIVER
account_circle
Colorectal THRIVE(@colothrive) 's Twitter Profile Photo

Cancer treatment shall be efficient AND meaningful to the Patient.
Broad consensus on the above - how to act on this varies hugely and is partially rooted in personal beliefs and experience as we are human. What do the data tell us for treatment of locoregional recurrence?

Cancer treatment shall be efficient AND meaningful to the Patient. Broad consensus on the above - how to act on this varies hugely and is partially rooted in personal beliefs and experience as we are human. What do the data tell us for treatment of locoregional recurrence?
account_circle